Search results for "Gene Therapies"

Webcast Viral Vector Production for Gene Therapy (in partnership with NIBRT)
In partnership with NIBRT, our eLearning course, “Viral Vector Production for Gene Therapy”, is available on the award winning NIBRT Online Academy.

Article The Role of CDMOs in Cell and Gene Therapy Process Development
Click here to read more >> An experienced contract development and manufacturing organization (CDMO) can ease scaling and tech transfer.

Article New Therapies Present Scaling Challenges
By Feliza Mirasol The approval of emerging biologic-based therapeutics—such as cell and gene therapies—presents challenges and decisions for drug companies looking to increase the manu…

Article Bracing for a Future Wave of Advanced Therapies
The biopharma industry has gone from seeing five gene therapy products approved within the span of five years (2017–2022) to witnessing breakthrough approvals for five gene therapies in just one year,…

Article Emerging Therapies Test Existing Bioanalytical Methods
Cellular and gene therapies are not new to the medical establishment. Cellular therapy, the transfer of live cells with a specific function to a patient to treat/cure a disease, was first successfully…

Article FDA Framework Spurs Advanced Therapies
Markets and Markets estimates the value of the regenerative medicine market (including cell and gene therapies, immunotherapies, and tissue engineering) will grow at a compound annual growth rate of 2…

Article Patenting Prospects for Cell-Based Therapies
Cell-based therapies are moving medical treatments forward, but intellectual property uncertainties may delay progress. By Kevin Noonan Treatment using cell-based therapies is a rapidl…

Article Scaling Up Novel Therapies
Developers are exploring how these platforms might be used in novel therapies such as cell and gene therapies. Although these treatments are in early stages of development, gene therapy has already be…

Article Science Focus Fuels Successful Process Development for Startups
For Krystal Biotech, which is developing gene therapies for skin diseases using a new vector for delivery, process development has involved cell-line engineering as well as determination of the optimu…

Article Biopharma Seeks Balance
New paradigm: Gene and cell therapies FDA’s approval of the first cell and gene therapies in 2017 created new dynamics in the biopharma industry as well as new science, technology, business, and e…

Previous PageNext Page